Pulmatrix, Inc. (PULM) Cash Flow Statement

NASDAQ: PULMOperating cash, capex, free cash flow and buybacks.

Where PULM’s cash came from and went, 2025

December 31, 2025 · U.S. dollars
Cash from operations
−$5.4M
Capital expenditures
$0
Free cash flow
−$5.4M
Returned to shareholders
—
Change in cash
−$5.4M
cash at year-end $4.1M
Drawn from cash: $5.4MDrawn from cash$5.4MCash used in operations: $5.4MCash used in operations$5.4M · 100%$5.4M
Cash from operations
−$5.4M
Change in cash
−$5.4M

Drawn to scale: where the cash came from and how it was used. Hover for values.

PULM operating cash flow, capex and free cash flow

Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)

PULM cash flow trends, 2016–2025

Pulmatrix, Inc. cash flow trends
MetricTrendThenLatestChange
Operating cash flow−$13.2M2016−$5.4M2025—
Capital expenditures$455,0002016$02025−100.0%
Free cash flow−$13.7M2016−$5.4M2025—
Free cash flow margin−1,640.5%2016−142.4%2024+1,498.1 pts
Stock-based compensation$4.0M2016$25,0002025−43.1%/yr
Dividends paid$02016$3.2M2021—
Share buybacks (net)$02016$152,0002022—
Capex / revenue54.5%20165.1%2024−49.4 pts

Change is the average annual growth (CAGR) or the difference between the first and latest year.

PULM cash flow by activity

OperatingInvestingFinancingChange in cash

PULM net income vs operating cash flow

Net incomeOperating cash flow

Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).

PULM cash flow statement

Pulmatrix, Inc. annual cash flow statement
2025202420232022202120202019201820172016
Operating activities
Net income−$5.2M−$9.6M−$14.1M−$18.8M−$20.2M−$19.3M−$20.6M−$20.6M−$18.1M−$27.8M
Depreciation & amortization$0$435,000$1.5M$1.5M$1.2M$1.0M$765,000$231,000$246,000$250,000
Stock-based compensation$25,000$511,000$954,000$1.1M$1.2M$1.2M$2.1M$3.0M$2.8M$4.0M
Change in working capital−$229,000−$4.8M−$4.3M−$3.2M−$5.5M−$4.7M$13.7M$484,000$345,000$371,000
Other non-cash items−$67,000$2.7M$8,000$0$3.6M$9.3M$7.3M$114,000$170,000$10.0M
Cash from operating activities−$5.4M−$10.7M−$16.0M−$19.4M−$19.7M−$12.5M$3.2M−$16.8M−$14.5M−$13.2M
Investing activities
Capital expenditures$0−$398,000−$676,000−$86,000−$144,000−$281,000−$58,000−$19,000−$74,000−$455,000
Investments (net)—−$398,000−$380,000−$86,000−$144,000−$281,000−$58,000−$19,000−$74,000−$431,000
Acquisitions & other investing—$398,000$380,000$86,000$144,000$281,000$58,000$19,000$74,000$455,000
Cash from investing activities—−$398,000−$676,000−$86,000−$144,000−$281,000−$58,000−$19,000−$74,000−$431,000
Financing activities
Dividends paid————−$3.2M———$0$0
Share repurchases & issuance (net)———−$152,000—$21.0M$17.7M$19.3M$16.6M$0
Net borrowing (repayment)————$0——−$3.3M−$2.7M−$1.0M
Shares issued$0$0$53,000$1.4M$43.3M$7.3M$17.5M$19.3M$0$0
Other financing—$0$0$0$3.4M−$7.3M−$17.5M−$19.5M$0$0
Cash from financing activities—$0$53,000$1.2M$43.5M$21.0M$17.7M$15.8M$13.9M−$1.0M
Summary
Net change in cash−$5.4M−$11.1M−$16.6M−$18.2M$23.6M$8.2M$20.9M−$987,000−$632,000−$14.7M
Cash at end of period$4.1M$9.5M$20.6M$37.3M$55.5M$31.9M$23.6M$2.6M$3.5M$4.2M
Free cash flow−$5.4M−$11.1M−$16.7M−$19.4M−$19.9M−$12.8M$3.2M−$16.8M−$14.6M−$13.7M
Free cash flow margin—−142.4%−228.3%−320.2%−384.4%−101.0%40.1%−10,967.3%−4,343.6%−1,640.5%
Capex / revenue—5.1%9.3%1.4%2.8%2.2%0.7%12.4%22.1%54.5%

Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.

PULM cash generation

In fiscal 2025 (ended December 31, 2025), Pulmatrix generated -$5.4 million of cash from operations and spent $0 on capital expenditures, leaving free cash flow of -$5.4 million. Cash and equivalents fell by $5.4 million over the year.

Related: PULM income statement, PULM balance sheet. See the PULM stock overview for the latest quote and news.

PULM cash flow FAQ

What is Pulmatrix's free cash flow?

Pulmatrix's free cash flow was -$5.4 million in fiscal 2025: -$5.4 million of operating cash flow minus $0 of capital expenditures It was -$11.1 million a year earlier..

How much cash does Pulmatrix generate from operations?

Pulmatrix generated -$5.4 million of cash from operating activities in fiscal 2025.

Biotechnology: cash flow